Characterization of pancreastatin receptor and signaling in rat HTC hepatoma cells

European Journal of Pharmacology

Volumn 397, Issue 2-3, 2000, Pages 229-235

  Sánchez Margalet, Víctor ^a   González Yanes, Carmen ^a   Santos Alvarez, José ^a   Najib, Souad ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

G protein; HTC cell; Insulin resistance; MAPK; Pancreastatin receptor; Phospholipase C; Signaling

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PANCREASTATIN; PHOSPHOLIPASE C;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HEPATOMA CELL; HORMONE RECEPTOR INTERACTION; INSULIN RESISTANCE; LIVER MEMBRANE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BINDING, COMPETITIVE; CARCINOMA, HEPATOCELLULAR; CELL MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; GTP-BINDING PROTEINS; MAP KINASE SIGNALING SYSTEM; PANCREATIC HORMONES; PHOSPHOLIPASE C; PROTEIN BINDING; RATS; RECEPTORS, GASTROINTESTINAL HORMONE; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0343527947     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00253-3     Document Type: Article

References (48)

1. Abood M.E., Eberwine J.H. Characterization and regulation of a cDNA clone for rat pancreastatin. Biochem. Biophys. Res. Commun. 167:1990;1079-1085.
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
3. Eskeland N.L., Zhou A., Dihn T.Q., Wu H., Parmer R.J., Mains E., O'Connor D.T. Chromogranin A processing and secretion. Specific role of endogenous and exogenous prohormone convertases in the regulated secretory pathway. J. Clin. Invest. 98:1996;148-156.
4. Exton J.H. Regulation of phosphoinositide phospholipases by hormones, neurotransmitters, and other agonists linked to G proteins. Annu. Rev. Pharmacol. Toxicol. 36:1996;481-509.
5. Funakoshi A., Tateishi K., Shinozaki H., Matsumoto M., Wakasugi H. Elevated plasma levels of pancreastatin (PST) in patients with non-insulin-dependent diabetes mellitus (NIDDM). Regul. Pept. 30:1990;159-164.
6. Gutkind J.S. The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J. Biol. Chem. 273:1998;1839-1842.
7. Häring H.U., Mehnert H. Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: candidates for signal transmitter defect causing insulin resistance of the skeletal muscle. Diabetologia. 36:1993;176-182.
8. 11α. Activation of phospholipase C isoenzymes by Gα subunits. J. Biol. Chem. 268:1993;14367-14375.
9. Hunter W.M., Greenwood F.C. The preparation of 125I-labeled human growth hormone of high specific radioactivity. Nature. 19:1962;495-496.
10. Iacangelo A.L., Affolter H.U., Eiden L.E., Herbert E., Grimes M. Bovine chromogranin A sequence and distribution of its messenger RNA in endocrine tissues. Nature. 323:1986;82-86.
11. Iacangelo A.L., Fischer-Colbrie R., Koller K.J., Brownstein M.J., Eiden L.E. The sequence of porcine chromogranin A messenger RNA demonstrates chromogranin A can serve as the precursor for the biologically active hormone, pancreastatin. Endocrinology. 15:1988;2339-2341.
12. Iacangelo A.L., Okayama H., Eiden L.E. Primary structure of rat chromogranin A and distribution of its mRNA. FEBS Lett. 227:1988;115-121.
13. 4. Nature. 227:1970;680-685.
14. Parmer R.J., Koop A.H., Handa M.T., O'Connor D.T. Molecular cloning of chromogranin A from rat pheochromocytoma cells. Hypertension. 14:1989;435-444.
15. Parmer R.J., Xi X.-P., Wu H.-J., Helman L.J., Petz L.N. Secretory protein traffic. Chromogranin A contains a dominant targeting signal for the regulated pathway. J. Clin. Invest. 92:1993;1042-1054.
16. Payne D.M., Rossomando A.J., Martino P., Erickson A.K., Her J.H., Shabanowitz J., Hunt D.F., Weber M.J., Sturgill T.W. Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). EMBO J. 10:1991;885-892.
17. Quiao L.Y., Goldberg J.L., Russell J.C., Sun X.J. Identification of enhanced serine kinase activity in insulin resistance. J. Biol. Chem. 274:1999;10625-10632.
18. Sánchez V., Calvo J.R., Goberna R. Glycogenolytic effect of pancreastatin in the rat. Biosci. Rep. 10:1990;87-91.
19. 2+-dependent mechanism. Biochem. J. 284:1992;659-662.
20. Sánchez-Margalet V. Modulation of insulin receptor signalling by pancreastatin in HTC hepatoma cells. Diabetologia. 42:1999;317-325.
21. Sánchez-Margalet V. Insulin-stimulated glycogen synthesis requires S6 kinase and phosphatidylinositol-3-kinase in HTC-IR cells. J. Cell. Physiol. 182:2000;182-188.
22. Sánchez-Margalet V., Goberna R. Pancreastatin, a new peptide associated with essential hypertension and hyperinsulinemia. Galteau M.M., Henny J., Siest G. Biologie Prospective. 1993;575-580 Libbey, Paris.
23. Sánchez-Margalet V., Goberna R. Pancreastatin inhibits insulin-stimulated glycogen synthesis but not glycolysis in rat hepatocytes. Regul. Pept. 51:1994;215-220.
24. Sánchez-Margalet V., Goberna R. Pancreastatin activates pertussis toxin-sensitive guanylate cyclase and pertusis toxin-insensitive phospholipase C in rat liver membranes. J. Cell. Biochem. 55:1994;173-181.
25. Sánchez-Margalet V., González-Yanes C. Pancreastatin inhibits insulin action in rat adipocytes. Am. J. Physiol. 275:1998;E1055-E1060.
26. Sánchez-Margalet V., Santos-Alvarez J. Solubilization and molecular characterization of pancreastatin receptors from rat liver membranes. Endocrinology. 138:1997;1712-1718.
27. Sánchez-Margalet V., Calvo J.R., Goberna R. Glycogenolytic and hyperglycemic effect of 33-49 C-terminal fragment of pancreastatin in the rat in vivo. Horm. Metab. Res. 34:1992;455-457.
28. 2+ in rat hepatocytes involving both pertussis-toxin-sensitive and insensitive mechanisms. Biochem. J. 294:1993;439-442.
29. Sánchez-Margalet V., Valle M., Goberna R. Receptors for pancreastatin in rat liver membranes: molecular identification and characterization by covalent cross-linking. Mol. Pharmacol. 46:1994;24-29.
30. Sánchez-Margalet V., Lucas M., Goberna R. Pancreastatin activates protein kinase C by stimulating the formation of 1,2-diacylglycerol in rat hepatocytes. Biochem. J. 303:1994;51-54.
31. Sánchez-Margalet V., Zoratti R., Sung C.K. Insulin-like growth factor-1 stimulation of cells induces formation of complexes containing phosphatidylinositol-3-kinase, guanosine triphosphatase-activating protein (GAP), and p62 GAP-associated protein. Endocrinology. 136:1995;316-321.
32. Sánchez-Margalet V., Valle M., Lobón J.A., Maldonado A., Escobar F., Oliván J., Perez-Cano R., Goberna R. Increased plasma pancreastatin-like immunoreactivity levels in non-obese patients with essential hypertension. J. Hypertens. 13:1995;251-258.
33. Sánchez-Margalet V., Valle M., Lobón J.A., Escobar-Jimenez F., Perez-Cano R., Goberna R. Plasma pancreastatin-like immunoreactivity correlates with plasma norepinephrine levels in essential hypertension. Neuropeptides. 29:1995;97-101.
34. Sánchez-Margalet V., Lucas M., Goberna R. Pancreastatin: further evidence for its consideration as a regulatory peptide. J. Mol. Endocrinol. 16:1996;1-8.
35. Sánchez-Margalet V., Lucas M., Goberna R. Pancreastatin action in the liver: dual coupling to different G proteins. Cell. Signal. 8:1996;9-12.
36. Sánchez-Margalet V., Santos-Alvarez J., Goberna R. Pancreastatin signaling in the liver. Teelken A., Korpf J. Neurochemistry: Cellular, Molecular and Clinical Aspects. 1997;589-593 Plenum, New York.
37. Sánchez-Margalet V., Lobón J.A., Gonzalez A., Escobar-Jimenez F., Goberna R. Increased plasma pancreastatin-like levels in gestational diabetes subjects. Correlation with plasma catecholamine levels. Diabetes Care. 21:1998;951-954.
38. i1,2 protein in rat hepatoma (HTC) plasma membranes. Cell. Mol. Life Sci. 55:1999;142-147.
39. 11 protein stimulation in rat liver membranes. Mol. Cell. Endocrinol. 143:1998;101-106.
40. 32P. J. Cell. Biochem. 73:1999;469-477.
41. q/11α in rat liver membranes. Hepatology. 27:1998;608-614.
42. Schonwasser D.C., Marais R.M., Marshall C.J., Parker P.J. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol. Cell. Biol. 18:1998;790-798.
43. Simon J.P., Bader M.F., Aunis D. Proteolytic processing of CGA in cultured chromaffin cells. Biochem. Biophys. Acta. 1051:1989;123-130.
44. Smith C.D., Uhing R.J., Snyderman R. Nucleotide regulatory protein-mediated activation of phospholipase C in human polymorfonuclear leukocytes is disrupted by phorbol esters. J. Biol. Chem. 262:1987;6121-6127.
45. Sung C.K., Sánchez-Margalet V., Goldfine I.D. Role of p85 subunit of phosphatidylinositol-3-kinase as an adaptor molecule linking the insulin receptor, p62 and GTPase-activating protein. J. Biol. Chem. 269:1994;12503-12507.
46. Tatemoto K., Efendic S., Mutt V., Makk G., Feistner G.J., Barchas J.C. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature. 324:1986;476-478.
47. Velloso L.A., Folli F., Sun X.J., White M.F., Saad M.J.A., Kahn C.R. Cross-talk between the insulin and angiotensin signaling systems. Proc. Natl. Acad. Sci. U. S. A. 93:1996;12490-12495.
48. Watkinson A., O'Sullivan A., Burgoyne R., Dockray G. Differential accumulation of catecholamines, proenkephalin-and CGA-derived peptides in the medium after chronic nicotine stimulation of cultured bovine adrenal chromaffin cells. Peptides. 11:1990;435-441.